Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.72 USD | +1.98% | -2.89% | +56.91% |
May. 14 | Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | North American Morning Briefing : More Earnings -2- | DJ |
Chart calendar Acrivon Therapeutics, Inc.
Upcoming events on Acrivon Therapeutics, Inc.
Past events on Acrivon Therapeutics, Inc.
2024-05-14 08:00 am | Q1 2024 Earnings Release |
2024-04-24 04:15 pm | R&D Day |
2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract Number :- 4749 |
2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Abstract Number :- 1977 |
2024-03-28 08:00 am | Q4 2023 Earnings Release |
2024-03-05 10:30 am | TD Cowen Health Care Conference |
2024-02-13 02:40 pm | Oppenheimer Healthcare Life Sciences Conference |
2024-01-11 02:15 pm | JPMorgan Healthcare Conference |
2023-11-28 08:30 am | Piper Sandler Healthcare Conference |
2023-11-09 08:01 am | Q3 2023 Earnings Release |
2023-10-14 12:30 pm | AACR-NCI-EORTC International Conference - Poster No: C002 |
2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Poster No: B012 |
2023-09-07 03:45 pm | Wells Fargo Healthcare Conference |
2023-09-05 | Citi BioPharma Conference |
2023-08-11 07:00 am | Q2 2023 Earnings Release |
2023-06-22 12:30 pm | Annual General Meeting |
2023-06-08 08:00 am | Jefferies Global Healthcare Conference |
2023-05-09 08:00 am | Q1 2023 Earnings Release |
2023-05-02 03:00 pm | H.C. Wainwright BioConnect Investor Conference |
2023-05-01 11:00 am | Investor Meeting |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -32,7 -39,7 17.74% | -67,1 -62,7 -7.04% | -80,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -31,2 -33,0 5.67% | -60,4 -58,3 -3.61% | -77,6 |
Net income Million USD | Released Forecast Spread | -16,2 | -31,2 -33,0 5.67% | -60,4 -58,3 -3.61% | -77,6 |
EPS USD | Released Forecast Spread | -3,78 | -7,56 -7,64 1.05% | -2,74 -2,63 -4.38% | -2,47 |
Announcement Date | 12/08/22 | 28/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -9,58 -10,0 4.25% | -9,95 -17,0 41.5% | -14,4 -13,5 -6.63% | -15,5 -15,6 0.39% | -16,1 -16,5 2.44% | -21,1 -17,0 -23.97% | -17,7 -21,0 15.71% | -20,4 | -20,7 | -21,1 | -23,5 | -24,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,20 -7,00 -31.4% | -8,93 -13,0 31.32% | -12,8 -12,3 -3.71% | -13,9 -14,1 1.59% | -14,5 -15,8 8.35% | -19,3 -16,5 -16.41% | -16,5 -19,8 16.86% | -20,2 | -21,1 | -21,8 | -23,5 | -24,0 |
Net income Million USD | Released Forecast Spread | -9,20 -7,00 -31.4% | -8,93 -13,0 31.32% | -12,8 -12,3 -3.71% | -13,9 -14,1 1.59% | -14,5 -15,8 8.35% | -19,3 -16,5 -16.41% | -16,5 -19,8 16.86% | -20,2 | -21,1 | -21,8 | -23,5 | -24,0 |
EPS USD | Released Forecast Spread | -5,17 -3,95 -30.89% | -0,80 -1,38 42.03% | -0,58 -0,63 8.3% | -0,63 -0,64 2.07% | -0,66 -0,72 7.69% | -0,87 -0,73 -20% | -0,73 -0,84 13.35% | -0,59 | -0,56 | -0,56 | -0,64 | -0,67 |
Announcement Date | 15/12/22 | 28/03/23 | 09/05/23 | 11/08/23 | 09/11/23 | 28/03/24 | 14/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Acrivon Therapeutics, Inc.
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACRV Stock
- Calendar Acrivon Therapeutics, Inc.